tiprankstipranks
Advertisement
Advertisement

Twist Bioscience raises FY26 revenue view $442M-$447M from $435M-$440M

Consensus $438.75M. Gross margin to be above 52% for fiscal 2026

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1